San Rocco Therapeutics Gains Bipartisan Support for Affordable Sickle Cell Cure

In a rare show of unity, San Rocco Therapeutics is being praised across the political spectrum for its mission to deliver a safe and accessible gene therapy for sickle cell disease. With backing from both Republican and Democratic leaders, the company stands out for challenging high-cost pharma models and putting patients first. As it prepares to resume clinical trials in the U.S. and Europe, San Rocco is showing that real innovation means ensuring cures reach those who need them most.

Read the full article here

Leave A Comment

At vero eos et accusamus et iusto odio digni goikussimos ducimus qui to bonfo blanditiis praese. Ntium voluum deleniti atque.

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)